Elvira O.G. van Vliet

Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial

Elvira O.G. van Vliet, Tobias A. J. Nijman, Ewoud Schuit et al. · The Lancet · 2016 · 95 citations

Fertility, Apostel Iii, Nifedipine Versus Atosiban +10

Placental pathology and long-term neurodevelopment of very preterm infants

Elvira O.G. van Vliet, Jorrit F. de Kieviet, J. Patrick van der Voorn et al. · American Journal of Obstetrics and Gynecology · 2012 · 79 citations · Full text

Developmental Biology, Prenatal Development, Placental Development +10

Placental histology in spontaneous and indicated preterm birth: A case control study

Tobias A. J. Nijman, Elvira O.G. van Vliet, Manon J.N.L. Benders et al. · Placenta · 2016 · 77 citations

Placental Histology, Case Control Study, Placental Development +11

Spiral artery remodeling and maternal cardiovascular risk

Jan H.W. Veerbeek, Laura Brouwers, Maria P.H. Koster et al. · Journal of Hypertension · 2016 · 46 citations

Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial

Tobias A. J. Nijman, Elvira O.G. van Vliet, Christiana A. Naaktgeboren et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2016 · 26 citations

Nifedipine Versus Placebo, Surgery, Medicine +3